Anixa Biosciences, Inc. Stock
Anixa Biosciences, Inc. Stock price
Key metrics
| Market capitalization | $107.59m |
| Enterprise Value | $91.99m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 6.70 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-13.14m |
| Free Cash Flow (TTM) Free Cash Flow | $-7.98m |
| Cash position | $15.60m |
Is Anixa Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.
Anixa Biosciences, Inc. Stock Analysis
Analyst Opinions
3 Analysts have issued a Anixa Biosciences, Inc. forecast:
Analyst Opinions
3 Analysts have issued a Anixa Biosciences, Inc. forecast:
Financial data from Anixa Biosciences, Inc.
| Apr '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -13 -13 |
1%
1%
|
| Net Profit | -12 -12 |
5%
5%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Anixa Biosciences, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Anixa Biosciences, Inc. Stock News
Company Profile
Anixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the body's immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
| Head office | United States |
| CEO | Amit Kumar |
| Employees | 5 |
| Founded | 1982 |
| Website | www.anixa.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
